Dear Research Advocate: The government is now in its sixth day of a partial shutdown that has left agencies including the Food and Drug Administration (FDA) and National Science Foundation (NSF) without the necessary resources to conduct their critical, multi-faceted work. Negotiations between the Congress and the White House reportedly remain at a stalemate. Last year, when the House and Senate voted to end a weeklong shutdown, Senate Majority Leader McConnell said he hoped everyone could remember that "brinksmanship and hostage-taking do not work. They make bipartisan progress harder – not easier – to achieve." Let’s face it: no one is heeding that lesson now. The path that will truly...
Looking back at 2018, it is important to note the amazing contributions that have been made to science, research and advocacy made by some truly outstanding individuals. Research!America has had the honor of featuring a few of these science leaders as guest contributors to our blog, which gives us the opportunity to share their work and opinions on a broader scale. As the year comes to a close, we’d like to take a moment to look back at our 10 most popular guest blog posts from 2018. 1. Study Explores the Role of Lifestyle Interventions in Fighting Alzheimer’s June 28: In our most-read blog, Heather Snyder, senior director of medical and scientific operations at the Alzheimer’s Association...
Dear Research Advocate: Today, our nation and world lost a research leader whose vision, commitment and compassion have catalyzed progress against a host of insidious health threats. Dr. Stephen Katz , the director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, died suddenly and unexpectedly this morning. We have been blessed by you and your service, and will miss you, Steve. The Senate passed a continuing resolution (CR) last night to flat-fund seven fiscal year 2019 appropriations bills at 2018 levels until February 8, 2019. (Recall that the federal fiscal year began on October 1, so this is not a minor delay.) It was fully expected that the House would pass...
Dear Research Advocate: Research!America had the opportunity this week to attend a Senate NIH Caucus meeting featuring Dr. Jennifer Doudna, the world-renowned biochemist at UC Berkeley, who is a pioneer in the field of gene editing. A big thank you to Jed Manocherian and ACT for NIH for working with Senator Dick Durbin (D-IL) to bring Dr. Doudna to Capitol Hill to discuss the powerful new technology known as CRISPR, which has potentially curative applications for diseases such as sickle cell and cancer. Here is a list of current Senate NIH Caucus members. Take a moment to send your Senators an email urging them to join if they are not already members. Congress has just six days to act...
The December 2018 Research Advocate is now online . Highlights from this month include: The announcement of Siddhartha Mukherjee, MD, DPhil, as the recipient of the Isadore Rosenfeld Award for Impact on Public Opinion . Research!America's new survey revealing public opinion about antibiotic resistance. Jennifer Luray has joined Research!America as Senior Advisor. Recaps of the Post-Election Briefing and Public Health Thank You Day. Member Spotlight: George Washington University School of Medicine and Health Sciences . You can also download the entire newsletter as a PDF .
Dear Research Advocate: Votes and other Congressional activities were suspended this week to mourn the passing of our nation’s 41st President, George H.W. Bush. To prevent a government shutdown and provide more time to resolve disagreement around border wall funding, Congress agreed to another continuing resolution (CR) – now awaiting the President’s signature – to extend flat-funding for all remaining federal departments and agencies, including FDA and NSF, until December 21. This end-of-year CR scenario is all too familiar to advocates, and we must all stay the course to secure passage this year. Yesterday, Research!America and the Alliance for Aging Research sent a joint letter to...
Antibiotic resistance (also known as anti-microbial resistance, or AMR) is a growing public health threat. In a recent national opinion survey , over 80% of Americans said they are concerned that antibiotic resistance will make infections more difficult or impossible to treat, and could even become deadly. However, when it comes to the details, survey data indicated that few are aware of what can be done to slow the progression of antibiotic resistance. Therefore, in honor of Antibiotics Awareness Week, Research!America hosted a guest blog series to highlight the work of some amazing initiatives that are leading the crusade against anti-microbial resistance. To provide the academic...

Sidebar Quote

Funding research gives all of us a better chance of living a healthier life.
Pam Hirata, heart disease survivor